Merial and Newport Laboratories have announced an agreement to allow Newport to manufacture and distribute Merial’s autogenous porcine circovirus type 2 (PCV-2) swine vaccines through Newport’s veterinarian and swine integrator customer base.
"Merial will contribute product technical support through a working relationship with Newport Labs. Newport will contribute its sales and marketing capability, including strong relationships with top swine veterinarians, swine producers and key influence leaders," said Steve Parker, director of Swine Marketing, Merial US Region.
Source: Merial Press Release, 3/10/09